Pliant Therapeutics, Inc. (PLRX) ownership: Top institutional holder: TANG CAPITAL MANAGEMENT LLC ($7.74M). Insider activity: Net Seller (0 buys, 20 sells). SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 6143132.00 | $7.74M | 2026-03-31 |
| CITADEL ADVISORS LLC | 3226599.00 | $4.07M | 2026-03-31 |
| Blue Owl Capital Holdings LP | 2969199.00 | $3.74M | 2026-03-31 |
| VANGUARD GROUP INC | 2818241.00 | $3.44M | 2025-12-31 |
| ADAR1 Capital Management, LLC | 2585126.00 | $3.26M | 2026-03-31 |
| ACADIAN ASSET MANAGEMENT LLC | 2416508.00 | $3.04M | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 2343101.00 | $2.95M | 2026-03-31 |
| TWO SIGMA INVESTMENTS, LP | 2253138.00 | $2.84M | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-04-17 | |
| Sell | null | 2026-04-17 | |
| Sell | null | 2026-04-17 | |
| Sell | null | 2026-04-17 | |
| Sell | null | 2026-04-17 | |
| Sell | null | 2026-04-17 | |
| Sell | null | 2026-04-17 | |
| Sell | null | 2026-04-17 |
Back to PLRX overview · PLRX earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.